Table 1 Baseline patient demographics and characteristics post propensity score matching
|  | Anti-platelet use (n = 42,192) | No antiplatelet use (n = 42,192) | Strictly standardised mean difference |
|---|---|---|---|
Demographics | |||
 Age at index event (years) | 62.8 ± 12.6 | 63.2 ± 12.7 | 0.029 |
 Sex (female) [%] | 58 | 57 | 0.007 |
 Race (White/Black or African American/Asian) [%] | 71/9/4 | 70/9/3 | 0.011/0.006/0.012 |
Anthropometrics | |||
 Body mass index (kg/m2) | 33.4 ± 7.6 | 33.9 ± 7.5 | 0.062 |
Comorbidities [%] | |||
 Type 2 diabetes | 33.8 | 33.4 | 0.009 |
 Ischaemic heart disease | 20.1 | 19.8 | 0.008 |
 History of any neoplasm | 14.4 | 14.8 | 0.012 |
 Cerebrovascular disease | 6.7 | 6.4 | 0.010 |
 Other peripheral vascular disease | 3.3 | 3.0 | 0.019 |